These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Kava, the anxiolytic herb: back to basics to prevent liver injury? Teschke R; Sarris J; Glass X; Schulze J Br J Clin Pharmacol; 2011 Mar; 71(3):445-8. PubMed ID: 21284704 [TBL] [Abstract][Full Text] [Related]
5. [Acute hepatitis due to kava-kava and St John's Wort: an immune-mediated mechanism?]. Teschke R Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1880-1; author reply 1882-3. PubMed ID: 16915552 [No Abstract] [Full Text] [Related]
6. Kava: a test case for Canada's new approach to natural health products. Boon HS; Wong AH CMAJ; 2003 Nov; 169(11):1163-4. PubMed ID: 14638650 [No Abstract] [Full Text] [Related]
7. By the way, doctor. Your article about anxiety in the March 2002 issue neglected to mention the herb kava as a treatment for anxiety. I've been using it, and I thought its effectiveness for anxiety was widely accepted. Why did you omit it? Robb-Nicholson C Harv Womens Health Watch; 2002 Apr; 9(8):8. PubMed ID: 11959540 [No Abstract] [Full Text] [Related]
8. Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia. Russmann S; Barguil Y; Cabalion P; Kritsanida M; Duhet D; Lauterburg BH Eur J Gastroenterol Hepatol; 2003 Sep; 15(9):1033-6. PubMed ID: 12923378 [TBL] [Abstract][Full Text] [Related]
9. Are kavalactones the hepatotoxic principle of kava extracts? The pitfalls of the glutathione theory. Schmidt M J Altern Complement Med; 2003 Apr; 9(2):183-7; author reply 187-8. PubMed ID: 12804070 [No Abstract] [Full Text] [Related]
11. The curious case of Kava. Grossman L Time; 2002 Apr; 159(14):58. PubMed ID: 11951318 [No Abstract] [Full Text] [Related]
12. Liver transplantation and the use of KAVA: Case report. Becker MW; Lourençone EMS; De Mello AF; Branco A; Filho EMR; Blatt CR; Mallmann CA; Schneider M; Caregnato RCA; Blatt CR Phytomedicine; 2019 Mar; 56():21-26. PubMed ID: 30668342 [TBL] [Abstract][Full Text] [Related]
13. Impact of federal safety advisories on health food store advice. Mills E; Singh R; Ross C; Ernst E; Wilson K J Gen Intern Med; 2004 Mar; 19(3):269-72. PubMed ID: 15009783 [TBL] [Abstract][Full Text] [Related]
14. [Acute hepatitis due to kava-kava and St John's Wort: an immune-mediated mechanism?]. Siegers CP; Schmidt M Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1881-2; author reply 1882-3. PubMed ID: 16915554 [No Abstract] [Full Text] [Related]
15. Sale of kava extract in some health food stores. Mills E; Singh R; Ross C; Ernst E; Ray JG CMAJ; 2003 Nov; 169(11):1158-9. PubMed ID: 14638649 [TBL] [Abstract][Full Text] [Related]
16. Tradition and toxicity: evidential cultures in the kava safety debate. Baker JD Soc Stud Sci; 2011 Jun; 41(3):361-84. PubMed ID: 21879526 [TBL] [Abstract][Full Text] [Related]
17. Kava hepatotoxicity: comparative study of two structured quantitative methods for causality assessment. Teschke R; Fuchs J; Bahre R; Genthner A; Wolff A J Clin Pharm Ther; 2010 Oct; 35(5):545-63. PubMed ID: 20831679 [TBL] [Abstract][Full Text] [Related]
18. Relevant hepatotoxic effects of kava still need to be proven. A statement of the Society for Medicinal Plant Research. Society for Medicinal Plant Research Planta Med; 2003 Nov; 69(11):971-2. PubMed ID: 14735431 [No Abstract] [Full Text] [Related]
19. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate? Teschke R; Wolff A Regul Toxicol Pharmacol; 2011 Feb; 59(1):1-7. PubMed ID: 20854865 [TBL] [Abstract][Full Text] [Related]
20. Kava: a comprehensive review of efficacy, safety, and psychopharmacology. Sarris J; LaPorte E; Schweitzer I Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]